Ligand Pharmaceuticals LGND Insider Ownership

NASDAQ LGND

$309.41 +12.13 (+4.08%)

As of: Oct 20, 2026 · 1:32 PM EDT

Insider Holdings by Owner

1.17Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

2.51%

▼-0.290% pp QoQ

Shares Held by Insiders

504.24K

filed for Sep 2026

▼-10.33% QoQ

Shares Outstanding

20.06Mn

20,063,000 shares

Direct Holdings

486.22K

Indirect: 18.03K

Net Shares Traded (QoQ)

-58.09K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 8, 2026

Over the past 12 months, Ligand Pharmaceuticals insiders sold $34.73 million of stock on the open market (137.71K shares) and made no open-market purchases.

A count shows 9 insiders selling LGND stock on the open market over the past 12 months and none buying.
Octavio Espinoza (Chief Financial Officer) sold the most Ligand Pharmaceuticals stock on the open market over the past 12 months, $13.03 million (49.92K shares), most recently on August 12, 2026.
The newest open-market trade among Ligand Pharmaceuticals insiders came on October 2, 2026, when Andrew Reardon (CLO & Secretary) made a sale of 5K shares for $1.52 million.
In transactions other than open-market trades, Ligand Pharmaceuticals insiders received 104.33K shares in stock awards, acquired 101.87K shares through option exercises and conversions, gave up 56.48K shares to cover taxes or exercise prices and gave away 130 shares as gifts over the past 12 months.
Per Business Quant data, Ligand Pharmaceuticals insiders hold 499.58K shares in total based on their latest Form 4 filings, or 2.49% of the 20.06Mn shares outstanding; that total is down 11.16% from 562.33K shares at the end of Q2 2026.
Of the 499.58K shares held by Ligand Pharmaceuticals insiders, 481.56K shares (96.39%) are held directly and 18.02K shares (3.61%) indirectly, through trusts, partnerships, family members and other entities.
LGND's insider total is spread across 10 insiders who have filed a Form 4 in the past two years.
Ligand Pharmaceuticals' top three insider holders by shares held are Todd C. Davis (Chief Executive Officer, 199.51K shares), Jason Aryeh (Director, 120.61K shares) and John W. Kozarich (Director, 42.62K shares).
Todd C. Davis alone accounts for 39.94% of the shares held by Ligand Pharmaceuticals insiders.
Over the past 12 months, 10 insiders reported transactions in Ligand Pharmaceuticals stock in 51 Form 4 filings.
These insider figures for Ligand Pharmaceuticals are based on Form 4 filings through October 6, 2026.

Form 4 Holdings

Insiders Holding LGND

Insiders 17

Shares held 1.17Mn

Of outstanding 5.83%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	John L Higgins	Chief Executive Officer	417,695	417,695	35.7%	30 Dec, 2022
2	Todd C Davis	Chief Executive Officer	199,513	199,513	17.1%	06 Jul, 2026
3	Matthew W Foehr	President And Coo	162,187	162,187	13.9%	03 Nov, 2022
4	Jason Aryeh	Director	102,580	102,580	8.8%	12 Jun, 2026
5	Matthew E Korenberg	President Coo	50,777	50,777	4.3%	24 Sep, 2024
6	John W Kozarich	Director	42,622	42,622	3.6%	09 Jun, 2026
7	Stephen L Sabba	Director	33,629	33,629	2.9%	18 Jun, 2026
8	Andrew Reardon	Clo Secretary	31,854	31,854	2.7%	06 Oct, 2026
9	Sunil Patel	Other	28,820	28,820	2.5%	03 Nov, 2022
10	Octavio Espinoza	Chief Financial Officer	27,696	27,696	2.4%	13 Aug, 2026
11	John L Lamattina	Director	26,969	26,969	2.3%	12 Jun, 2026
12	Charles S Berkman	Svp, Gen. Counsel Secretary	23,825	23,825	2.0%	03 Nov, 2022
13	Nancy Ryan Gray	Director	8,930	8,930	0.8%	09 Jun, 2026
14	Jason Haas	Director	3,981	3,981	0.3%	13 Aug, 2026
15	Martine Zimmermann	Director	3,782	3,782	0.3%	24 Sep, 2026
16	Sarah Boyce	Other	2,892	2,892	0.2%	03 Nov, 2022
17	Jennifer R. Cochran	Other	1,161	1,161	0.1%	03 Nov, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

2,202 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
02 Oct, 2026	Andrew Reardon	Clo Secretary	Acquired M	340	$52.27	$17.77K	36,854	Direct
02 Oct, 2026	Andrew Reardon	Clo Secretary	Disposed S	833	$302.51	$251.99K	36,021	Direct
02 Oct, 2026	Andrew Reardon	Clo Secretary	Disposed S	1,976	$303.54	$599.80K	34,045	Direct
02 Oct, 2026	Andrew Reardon	Clo Secretary	Disposed S	1,535	$304.52	$467.43K	32,510	Direct
02 Oct, 2026	Andrew Reardon	Clo Secretary	Disposed S	404	$306.18	$123.70K	32,106	Direct
02 Oct, 2026	Andrew Reardon	Clo Secretary	Disposed S	235	$307.19	$72.19K	31,871	Direct
02 Oct, 2026	Andrew Reardon	Clo Secretary	Disposed S	17	$307.74	$5.23K	31,854	Direct
02 Oct, 2026	Andrew Reardon	Clo Secretary	Disposed M	340	$0.00	$0	29,104	Direct
22 Sep, 2026	Martine Zimmermann	Director	Disposed F	115	$298.50	$34.33K	3,782	Direct
10 Sep, 2026	Martine Zimmermann	Director	Disposed S	1,200	$285.00	$342.00K	3,897	Direct
03 Sep, 2026	Andrew Reardon	Clo Secretary	Disposed S	300	$283.99	$85.20K	41,214	Direct
03 Sep, 2026	Andrew Reardon	Clo Secretary	Disposed S	1,800	$285.17	$513.30K	39,414	Direct
03 Sep, 2026	Andrew Reardon	Clo Secretary	Disposed S	2,115	$286.36	$605.65K	37,299	Direct
03 Sep, 2026	Andrew Reardon	Clo Secretary	Disposed S	385	$287.53	$110.70K	36,914	Direct
03 Sep, 2026	Andrew Reardon	Clo Secretary	Disposed S	400	$288.98	$115.59K	36,514	Direct
12 Aug, 2026	Octavio Espinoza	Chief Financial Officer	Acquired M	16,179	$52.84	$854.90K	43,875	Direct
12 Aug, 2026	Jason Haas	Director	Acquired M	6,138	$51.56	$316.48K	11,119	Direct
12 Aug, 2026	Octavio Espinoza	Chief Financial Officer	Acquired M	2,074	$70.04	$145.26K	45,949	Direct
12 Aug, 2026	Jason Haas	Director	Disposed S	7,138	$292.81	$2.09Mn	3,981	Direct
12 Aug, 2026	Octavio Espinoza	Chief Financial Officer	Acquired M	2,869	$55.75	$159.95K	48,818	Direct

Showing 1 to 20 of 2,202 transactions